This report titled ‘Fertility Market in the US 2016-2020‘, provides an in-depth analysis of the market in terms of revenue and emerging trends. This market study also presents up to date analysis and forecasts for various market segments and all geographical regions.
Request sample report: http://bit.ly/1PRPZM6
“In 2015, the fertility drugs market in the US generated close to USD 1.22 billion in revenue and is likely to reach around USD 1.48 billion by 2020. Merck and Ferring Pharmaceuticals emerged as the leading sellers of fertility drugs in 2015. The sales of fertility drugs in the US is anticipated to rise further due to growing instances of infertility caused by obesity and stress in the region,” said Brahadeesh Chandrasekaran, one of Technavio’s lead analysts for orthopedics and general medical devices research.
“Assisted reproductive technology also known as ART, are the fertility procedures acting as the main revenue generating source for the fertility market in the US. These procedures involve surgical removal of eggs from a woman's ovaries, combining eggs with the intended sperm in a laboratory, followed by implantation into the womb. Of these, In vitro fertilization (IVF) is the most prevalent infertility treatment in the region, which accounted for more than 99% of all ART treatments,” added Brahadeesh.
Some of the other driving forces behind the growth of the fertility market in the US are:
- Growing acceptance of same-sex marriages across US
- Increasing success rate of infertility treatment
- Rise in infertility complications
Growing acceptance of same-sex marriages across US
Social acceptance and improved legal regulations governing same-sex marriage have led to a rise in sperm donation and the use of fertility services. It is estimated that same-sex couples are parents for up to six million children in the country.
Invalidation of the Defence of Marriage Act in 2013 led to the demand for fertility services in the US for same sex couples. In addition, with the legalization of same-sex marriages in June 2015, many couples in the future are expected to use fertility services. The use of sperm donors by same-sex female couples has also increased from 15% before legalization, to 20% after legalization of same-sex marriages. This trend is expected to hugely impact the future of the fertility market in the US.
Increasing success rate of infertility treatment
Infertility treatments have significantly improved and expanded in the US market in recent years. With new medical developments in IVF and other ART procedures, the pregnancy rate in the US is expected to witness a manifold increase over the next four years. Currently, the pregnancy rate in the US is close to 40% in women under the age of 40. The success rates from frozen embryo transfer is also on the rise and is largely attributed to the continual R&D support for the fertility market in the US.
Some prominent research studies that are currently underway are as follows:
- To differentiate genetic mutations that cause infertility in humans from mutations that do not.
- To understand the effects of gynecologic disorders, such as tubal disease and PCOS, on fertility rates, prevention of infertility, and choice of infertility treatments.
- To use knowledge gained from basic stem cell research to understand reproductive processes and develop novel therapeutics for treating infertility.
- To enhance detection methods of abnormalities in preimplantation embryos and develop advanced technologies for preimplantation genetic diagnosis.
- To understand the long-term effects of ART interventions on parental and child health. In women, this includes the possible connection between ovulation induction and ovarian cancer, and in men, the transmission of impaired fertility.
Gaining a clear understanding of these aspects will help fertility clinics provide better support and treatment for infertility, increasing the use of fertility services.
Rise in infertility complications
With aging, the human body starts undergoing various physiological and hormonal changes. Infertility among women is also an age-related issue. Medically, women aged above 35 are susceptible to fertility complications.
In the US, many women wait until their 30s and 40s to have children. Research studies estimate that about 20% of women in the country have their first child after the age of 35. It is also estimated of the couples in the US who are experiencing fertility issues, close to one third are above the age of 35.
Women above 35 experience an infertility rate of over 35% in the country and close to 20% of women aged between 35 to 44 avail fertility services to increase their chances of pregnancy. Over the next four years, rising cases of infertility and fertility-related issues in the US will lead to a higher adoption and sales of fertility services.
Browse related reports:
- Global In-Vitro Fertilization (IVF) Devices Market 2015-2019
- Global Orthopedics and General Medical Devices Orthopedic Trauma Devices Market 2015-2019
- Global Orthopedics and General Medical Devices Cannula Market 2015-2019
- Psoriatic Arthritis Market 2015-2019
- Global Bone Graft and Substitute 2015-2019
- USA Orthopedics and General Medical Devices Regenerative Medicine Market 2016-2020
Purchase these three reports for the price of one by becoming a Technavio subscriber. Subscribing to Technavio’s reports allows you to download any three reports per month for the price of one. Contact firstname.lastname@example.org with your requirements and a link to our subscription platform.
Technavio is a leading global technology research and advisory company. The company develops over 2000 pieces of research every year, covering more than 500 technologies across 80 countries. Technavio has about 300 analysts globally who specialize in customized consulting and business research assignments across the latest leading edge technologies.
Technavio analysts employ primary as well as secondary research techniques to ascertain the size and vendor landscape in a range of markets. Analysts obtain information using a combination of bottom-up and top-down approaches, besides using in-house market modeling tools and proprietary databases. They corroborate this data with the data obtained from various market participants and stakeholders across the value chain, including vendors, service providers, distributors, re-sellers, and end-users.
If you are interested in more information, please contact our media team at email@example.com.